MORE - Monitoring Revlimid - Collecting of Patient Information From Myelodysplastic Syndrome (MDS) Italian National Registry

Clinical trial NCT01347944 · COMPLETED

Trial details

NCT number: NCT01347944
Sponsor: Celgene
Status: COMPLETED
Study type: OBSERVATIONAL

Myelodysplastic Syndrome

Start date: 2011-01-01
Primary completion: 2013-06-30
Enrollment: 149

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.